Keryx Biopharmaceuticals (Nasdaq: KERX) Chairman Michael Tarnok disclosed a purchase of 40,000 shares on 5/26 at $0.46 ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE